Saurav Kumar Jha, Mohammad Imran, Shoaib Anwaar, Philip M Hansbro, Keshav Raj Paudel, Yousuf Mohammed
{"title":"Mesenchymal stem cell membrane-coated nanoconstructs: why have they not yet found a home in clinical practice?","authors":"Saurav Kumar Jha, Mohammad Imran, Shoaib Anwaar, Philip M Hansbro, Keshav Raj Paudel, Yousuf Mohammed","doi":"10.1080/17435889.2024.2369495","DOIUrl":"10.1080/17435889.2024.2369495","url":null,"abstract":"","PeriodicalId":74240,"journal":{"name":"Nanomedicine (London, England)","volume":" ","pages":"1507-1510"},"PeriodicalIF":0.0,"publicationDate":"2024-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11321396/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141494464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Design and <i>in vitro</i> evaluation of <sup>223</sup>Ra/<sup>99m</sup>Tc-loaded spherical nano-hydroxyapatite in bone tumor therapy.","authors":"Yumei Wang, Yue Zhou, Dongliang Zhai, Hao Deng, Xiaoliang Chen","doi":"10.1080/17435889.2024.2365127","DOIUrl":"10.1080/17435889.2024.2365127","url":null,"abstract":"<p><p><b>Aim:</b> Nano-hydroxyapatite (nHA) is a good nanocarrier to load <sup>223</sup>Ra, but the low specific activity (sp.act.) of <sup>223</sup>Ra@nHA limits its application in medicine. <b>Methods:</b> We proposed a method for preparing nHA using PEG as a template, which significantly increases the sp.act of <sup>223</sup>Ra@nHA and a new method to loaded <sup>99m</sup>Tc for <i>in vivo</i> tracking. <b>Results:</b> The nHA synthesized using PEG as a template was associated with higher sp.act for <sup>223</sup>Ra in comparison to nHA with identical particle size and without PEG. The nHA load <sup>99m</sup>Tc-MDP was associated with higher labeling rate and stability in comparison to <sup>99m</sup>Tc. <b>Conclusion:</b> All these findings suggest that using PEG as a template and <sup>99m</sup>Tc-MDP could be the most effective of synthetic <sup>223</sup>Ra/<sup>99m</sup>Tc@nHA.</p>","PeriodicalId":74240,"journal":{"name":"Nanomedicine (London, England)","volume":" ","pages":"1557-1567"},"PeriodicalIF":0.0,"publicationDate":"2024-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11321400/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141621883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Valeriya Trusova, Ivan Karnaukhov, Andrey Zelinsky, Borys Borts, Igor Ushakov, Larysa Sidenko, Galyna Gorbenko
{"title":"Radiolabeling of bionanomaterials with technetium 99m: current state and future prospects.","authors":"Valeriya Trusova, Ivan Karnaukhov, Andrey Zelinsky, Borys Borts, Igor Ushakov, Larysa Sidenko, Galyna Gorbenko","doi":"10.1080/17435889.2024.2368454","DOIUrl":"10.1080/17435889.2024.2368454","url":null,"abstract":"<p><p>Radiolabeling of bionanomaterials with technetium-99m (<sup>99m</sup>Tc) has become a promising approach in combining the benefits of nanotechnology and nuclear medicine for diagnostic and therapeutic purposes. This review is intended to provide a comprehensive overview of the state-of-the-art of radiolabeling of bionanomaterials with <sup>99m</sup>Tc, highlighting the synthesis methods, labeling mechanisms, biological evaluation, physicochemical characterization and clinical applications of <sup>99m</sup>Tc-labeled bionanomaterials. Various types of nanomaterials are considered in the review, including lipid- and protein-based nanosystems, dendrimers and polymeric nanomaterials. Moreover, the review assesses the challenges presented by this emerging field, such as stability of the radiolabel, potential toxicity of the nanomaterials and regulatory aspects. Finally, promising future perspectives and areas of research development in <sup>99m</sup>Tc-labeled bionanomaterials are discussed.</p>","PeriodicalId":74240,"journal":{"name":"Nanomedicine (London, England)","volume":" ","pages":"1569-1580"},"PeriodicalIF":0.0,"publicationDate":"2024-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11321418/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141621890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ziyu Huang, Zhengsheng Chen, Teng Ye, Lei Luo, Juntao Zhang, Qing Li, Yang Wang, Bizeng Zhao
{"title":"Large extracellular vesicles from induced pluripotent stem cell-marrow stem cells enhance limb angiogenesis via ERK/MAPK.","authors":"Ziyu Huang, Zhengsheng Chen, Teng Ye, Lei Luo, Juntao Zhang, Qing Li, Yang Wang, Bizeng Zhao","doi":"10.1080/17435889.2024.2363743","DOIUrl":"10.1080/17435889.2024.2363743","url":null,"abstract":"<p><p><b>Aim:</b> This study aims to investigate the effects of large extracellular vesicles (EVs) induced by pluripotent stem cell-derived mesenchymal stem cells on lower limb ischemic disease and explore its potential mechanisms. <b>Materials & methods:</b> The pathology of muscles was accessed by H&E staining and immunofluorescence staining. <i>In vitro</i>, we conducted wound-healing assay, tube formation assay, RT qPCR, ELISA, RNA sequencing and proteomic analysis. <b>Results:</b> iMSCs-lEVs alleviated the injury of ischemic lower limb and promoted the recovery of lower limb function. <i>In vitro</i>, iMSCs-lEVs promoted the proliferation, migration, and angiogenesis of HMEC-1 cells by regulating the ERK/MAPK signing pathway. <b>Conclusion:</b> This study demonstrated that iMSCs-lEVs promoted endothelial cell angiogenesis via the ERK/MAPK signaling pathway, thereby improving function after lower limb ischemic injury.</p>","PeriodicalId":74240,"journal":{"name":"Nanomedicine (London, England)","volume":" ","pages":"1525-1539"},"PeriodicalIF":0.0,"publicationDate":"2024-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11321421/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141621887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Optimization of atorvastatin and quercetin-loaded solid lipid nanoparticles using Box-Behnken design.","authors":"Dimple S Lalchandani, Laltanpuii Chenkual, Kailas Sonpasare, Bishal Rajdev, Vgm Naidu, Naveen Chella, Pawan Kumar Porwal","doi":"10.1080/17435889.2024.2364585","DOIUrl":"10.1080/17435889.2024.2364585","url":null,"abstract":"<p><p><b>Aim:</b> The study explores the synergistic potential of atorvastatin (ATR) and quercetin (QUER)- loaded solid lipid nanoparticles (SLN) in combating breast cancer. <b>Materials & methods:</b> SLNs were synthesized using a high-shear homogenization method and optimized using Box-Behnken design. The SLNs were characterized and evaluated for their <i>in vitro</i> anticancer activity. <b>Results:</b> The optimized SLN exhibited narrow size distribution (PDI = 0.338 ± 0.034), a particle size of 72.5 ± 6.5 nm, higher entrapment efficiency (<90%), sustained release and spherical surface particles. The <i>in vitro</i> cytotoxicity studies showed a significant reduction in IC<sub>50</sub> values on MDA-MB-231 cell lines. <b>Conclusion:</b> We report a novel strategy of repurposing well-known drugs and encapsulating them into SLNs as a promising drug-delivery system against breast cancer.</p>","PeriodicalId":74240,"journal":{"name":"Nanomedicine (London, England)","volume":" ","pages":"1541-1555"},"PeriodicalIF":0.0,"publicationDate":"2024-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11321401/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141621889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Milan Paul, Sneha Das, Balaram Ghosh, Swati Biswas
{"title":"Tocopherol-human serum albumin nanoparticles enhance lapatinib delivery and overcome doxorubicin resistance in breast cancer.","authors":"Milan Paul, Sneha Das, Balaram Ghosh, Swati Biswas","doi":"10.1080/17435889.2024.2359357","DOIUrl":"10.1080/17435889.2024.2359357","url":null,"abstract":"<p><p><b>Introduction:</b> HER2, a tyrosine kinase receptor, is amplified in HER2-positive breast cancer, driving cell signaling and growth. <b>Aim:</b> This study aimed to combat multidrug resistance in Dox-insensitive breast adenocarcinoma by creating a nanoformulation therapy with a tyrosine kinase inhibitor. <b>Methodology:</b> Human serum albumin (HSA) was conjugated with α-D-tocopherol succinate to form nanoaggregates loaded with lapatinib (Lapa). <b>Results:</b> The resulting Lapa@HSA(VE) NPs were 117.2 nm in size and demonstrated IC50 values of 10.25 μg/ml on MCF7 (S) and 8.02 μg/ml on MCF7 (R) cell lines. <b>Conclusion:</b> Lapa@HSA(VE) NPs showed no hepatotoxicity, unlike free Lapa, as seen in acute toxicity studies in rats.</p>","PeriodicalId":74240,"journal":{"name":"Nanomedicine (London, England)","volume":" ","pages":"1431-1448"},"PeriodicalIF":0.0,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11318677/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141494466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Bibliometric analysis of research on the utilization of nanotechnology in diabetes mellitus and its complications.","authors":"Jiexin Zhang, Meng He, Guanbin Gao, Taolei Sun","doi":"10.1080/17435889.2024.2358741","DOIUrl":"10.1080/17435889.2024.2358741","url":null,"abstract":"<p><p><b>Aim:</b> To identify hotspots in this field and provide insights into future research directions. <b>Methods:</b> Publications were retrieved from the Web of Science Core Collection database. R Bibliometrix software, VOSviewer and CiteSpace were used to perform the bibliometric and visualization analyses. <b>Results:</b> The analysis comprised 468 publications from 58 countries, with the United States, China and India being the leading contributors. 'Gene therapy', 'nanoparticles' and 'insulin therapy' are the primary focuses. 'Green synthesis', 'cytotoxicity', 'bioavailability' and 'diabetic foot ulcers' have gained prominence, signifying high-intensity areas of interest expected to persist as favored research topics in the future. <b>Conclusion:</b> This study delves into recent frontiers and topical research directions and provides valuable references for further research in this field.</p>","PeriodicalId":74240,"journal":{"name":"Nanomedicine (London, England)","volume":"19 16","pages":"1449-1469"},"PeriodicalIF":0.0,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11318711/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141910196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jie Wang, Haifeng Zhang, Weiping Wan, Haijiao Yang, Jing Zhao
{"title":"Advances in nanotechnological approaches for the detection of early markers associated with severe cardiac ailments.","authors":"Jie Wang, Haifeng Zhang, Weiping Wan, Haijiao Yang, Jing Zhao","doi":"10.1080/17435889.2024.2364581","DOIUrl":"10.1080/17435889.2024.2364581","url":null,"abstract":"<p><p>Mortality from cardiovascular disease (CVD) accounts for over 30% of all deaths globally, necessitating reliable diagnostic tools. Prompt identification and precise diagnosis are critical for effective personalized treatment. Nanotechnology offers promising applications in diagnostics, biosensing and drug delivery for prevalent cardiovascular diseases. Its integration into cardiovascular care enhances diagnostic accuracy, enabling early intervention and tailored treatment plans. By leveraging nanoscale innovations, healthcare professionals can address the complexities of CVD progression and customize interventions based on individual patient needs. Ongoing advancements in nanotechnology continue to shape the landscape of cardiovascular medicine, offering potential for improved patient outcomes and reduced mortality rates from these pervasive diseases.</p>","PeriodicalId":74240,"journal":{"name":"Nanomedicine (London, England)","volume":"19 16","pages":"1487-1506"},"PeriodicalIF":0.0,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11318751/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141910195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rubina Qaiser, Fahad Pervaiz, Sobia Noreen, Hanasul Hanan, Hina Shoukat, Hassan Mahmood, Muhammad Azeem Ashraf
{"title":"Optimizing lornoxicam-loaded poly(lactic-co-glycolic acid) and (polyethylene glycol) nanoparticles for transdermal delivery: <i>ex vivo</i>/<i>in vivo</i> inflammation evaluation.","authors":"Rubina Qaiser, Fahad Pervaiz, Sobia Noreen, Hanasul Hanan, Hina Shoukat, Hassan Mahmood, Muhammad Azeem Ashraf","doi":"10.1080/17435889.2024.2359356","DOIUrl":"10.1080/17435889.2024.2359356","url":null,"abstract":"<p><p><b>Aim:</b> This study focused on developing a topical gel incorporating lornoxicam-loaded poly(lactic-co-glycolic acid) and polyethylene glycol (PLGA-PEG) blend nanoparticles to mitigate gastrointestinal (GIT) side effects and enhance therapeutic efficacy. <b>Materials & methods:</b> Synthesized nanoparticles were subjected to <i>in vitro</i> characterization, <i>ex vivo</i> permeation studies, and acute oral toxicity analysis post-incorporation into the gel using a S/O/W double emulsion solvent. <b>Results & conclusion:</b> The nanoparticles displayed a smooth, spherical morphology (170-321 nm) with increased entrapment efficiency (96.2%). LOX exhibited a permeation rate of 70-94% from the nanoparticle-infused gel, demonstrating favorable biocompatibility at the cellular level. The formulated gel, enriched with nanoparticles, holds promising prospects for drug-delivery systems and promising improved therapeutic outcomes for LOX.</p>","PeriodicalId":74240,"journal":{"name":"Nanomedicine (London, England)","volume":" ","pages":"1471-1485"},"PeriodicalIF":0.0,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11318691/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141494465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}